[Phase II study of etoposide (VP-16) in the form of intravenous injection for malignant lymphomas and acute leukemias: Hanshin Cooperative Study Group for Hematological Disorders].

Source:http://linkedlifedata.com/resource/pubmed/id/3469424

Download in:

View as

General Info

PMID
3469424